Trial document

drksid header


Trial Description

start of 1:1-Block title


Thromboelastometry in Acute Hemorrhage Induced by Traumatic Injury of the Brain - a pilot study.

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym


end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial


end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Injuries to the head and brain (traumatic brain injury) can lead to potentially life-threatening intracranial bleeding. Depending on the mechanism of injury, potentially life-threatening bleeding can also occur anywhere else in the body. In these patients, early support of the body's own coagulation system is a key factor in bleeding control. However, the therapy with coagulation factors and blood products is associated with a number of risks. Therefore, point-of-care available laboratory tests - such as thromboelastometry - are increasingly used to guide individualised coagulation therapy. The goal of this pilot study is to evaluate the feasibility of thromboelastometric guided coagulation therapy in patients with traumatic brain injury and suspected bleeding.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Traumatic brain injury (TBI) remains to be a major health and socioeconomic problem. After TBI progressive intracranial hemorrhage is one of the most devastating reasons for secondary brain damage. The presence of coagulopathy after TBI has not only been associated with progression of intracranial hemorrhage but has also been linked to increased rates of mortality. Therefore, an early and aggressive therapeutic approach towards coagulopathy is desirable in this group of patients. However, it has become evident over the last decade that the empiric and uncontrolled use of blood products and coagulation factors is associated with serious adverse events. Thus, the possibility to rapidly identify coagulopathy and treat it in a goal-directed manner seems to be of utmost importance in patients with TBI. Rotational thromboelastometry (ROTEM®) is a viscoelastic point-of-care applicable method for global assessment of hemostasis that provides first results within a few minutes. Its use in guiding coagulation management in the trauma setting has widely spread over the last years. However, data on viscoelastic guided coagulation management in patients with TBI are still missing. Therefore, the aim of this multi-center, prospective pilot study is to assess the feasibility of implementing a ROTEM®-guided coagulation management algorithm in patients with TBI and suspected hemorrhage treated in centers that do not use ROTEM® as part of their routine clinical practice. According to an amendment to the study protocol, the number of patients to be included was adapted after recruitment of patients had begun.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?


end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:


end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00011559
  •   2017/01/13
  •   [---]*
  •   yes
  •   Approved
  •   EK134/16, Ethik-Kommission an der Medizinischen Fakultät der RWTH Aachen
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   S06 -  Intracranial injury
  •   D68 -  Other coagulation defects
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Blood will be drawn to perform ROTEM® measurements (EXTEM and FIBTEM A5) as soon as possible after admission of a patient with severe TBI and suspicion of clinically relevant hemorrhage. These measurements will be used to guide the administration of hemostatic substances (tranexamix acid, fibrinogen or cryoprecipitate, platelet concentrate, prothrombin complex concentrate or fresh frozen plasma) in the included patients. The exact algorithm is described in the study protocol.
end of 1:N-Block interventions
start of 1:1-Block design


  •   Interventional
  •   [---]*
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Other
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The percentage of patients in whom the ROTEM® guided coagulation management algorithm has been started in regard to stepwise decision-making either in favor or against the suggested intervention, including action taken or the decision not to perform any intervention, according to EXTEM and FIBTEM A5 results within 60 minutes after admission of the patient to the hospital.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

1.) Time to first ROTEM® results after admission and after blood sampling. 2.) Time from admission to administration of agents suggested by the algorithm. 3.) Time from the first ROTEM® results to administration of agents suggested by the algorithm. 4.) Adherence to the algorithm and capturing reasons for non-adherence. (N.B.: Adherence will be defined as decision-making according to the algorithm within 60 minutes after initiation of the algorithm. Exact dosing of agents administered will not be taken into account.) 5.) ROTEM® results at 60 minutes after initiation of the algorithm. 6.) Additional systemic haemostatic interventions. 7.) Clinical outcome data as captured in the CENTER-TBI CRF.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Belgium
  •   Germany
  •   Hungary
  •   Spain
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment


  •   Actual
  •   2017/02/01
  •   40
  •   Multicenter trial
  •   International
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   no minimum age
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

1.) Clinical diagnosis of severe TBI (GCS≤8)
2.) Suspicion of clinically relevant hemorrhage
3.) Clinical indication for CT scan
4.) Presentation to the hospital within 24 hours after injury

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Severe pre-existing neurological disorder that would confound outcome asessements (according to CENTER-TBI)

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses


  • start of 1:1-Block address primary-sponsor
    • Institute for Research in Operative Medicine (IFOM)Private University Witten-Herdecke (UWH)
    • Mr.  Prof.  Marc  Maegele 
    • Ostmerheimerstrasse 200
    • 51109  Cologne
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Medical University of Vienna; Department of Anesthesiology, General Intensive Care and Pain Medicine
    • Mr.  Dr.  Johannes  Gratz 
    • Waehringer Guertel 18-20
    • 1090  Vienna
    • Austria
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
    • Mr.  Dr.  Johannes  Gratz 
    • Währinger Gürtel 18-20
    • 1090  Wien
    • Austria
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • CENTER-TBI, supported by the European Union 7th Framework Program (Project ID 602150) coordinated by Antwerp University Hospital
    • Wilrijkstraat 10
    • 2650  Edegern
    • Belgium
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state


  •   Recruiting complete, follow-up complete
  •   2018/01/01
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  •   Gratz J, Güting H, Thorn S, Brazinova A, Görlinger K, Schäfer N, Schöchl H, Stanworth S, Maegele M. Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study. Anaesthesia. 2019;74:883-890. doi: 10.1111/anae.14670.
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.